List of BlackThorn Therapeutics patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11289187 Multimodal biomarkers predictive of transdiagnostic symptom severity	Patent 11289187 was granted and assigned to BlackThorn Therapeutics on March, 2022 by the United States Patent and Trademark Office.	BlackThorn Therapeutics	BlackThorn Therapeutics	United States Patent and Trademark Office	11289187	March 29, 2022
‌ US Patent 10538530 Vasopressin receptor antagonists and products and methods related thereto	Patent 10538530 was granted and assigned to BlackThorn Therapeutics on January, 2020 by the United States Patent and Trademark Office.	BlackThorn Therapeutics	BlackThorn Therapeutics	United States Patent and Trademark Office	10538530	January 21, 2020
‌ US Patent 11244762 System and method for identifying transdiagnostic features shared across mental health disorders	Patent 11244762 was granted and assigned to BlackThorn Therapeutics on February, 2022 by the United States Patent and Trademark Office.	BlackThorn Therapeutics	BlackThorn Therapeutics	United States Patent and Trademark Office	11244762	February 8, 2022
‌ US Patent 11139083 Machine learning-based diagnostic classifier	Patent 11139083 was granted and assigned to BlackThorn Therapeutics on October, 2021 by the United States Patent and Trademark Office.	BlackThorn Therapeutics	BlackThorn Therapeutics	United States Patent and Trademark Office	11139083	October 5, 2021
‌ US Patent 11186577 Vasopressin receptor antagonists and products and methods related thereto	Patent 11186577 was granted and assigned to BlackThorn Therapeutics on November, 2021 by the United States Patent and Trademark Office.		BlackThorn Therapeutics	United States Patent and Trademark Office	11186577	November 30, 2021